Establishment Labs Holdings (ESTA) EBITDA Margin (2017 - 2026)
Establishment Labs Holdings (ESTA) posted EBITDA Margin of 6.35% for Q2 2026, up 41.59% on a QoQ basis from 10.87% in Q1 2026, and up 2115.0% year-over-year from 0.29% in Q2 2025.
Powered by 
Analysis
Establishment Labs Holdings (ESTA) EBITDA Margin (2017 - 2026) Analysis & Trends
Establishment Labs Holdings has reported EBITDA Margin for 10 years, with the latest figure at 6.35% in Q2 2026.
- On a quarterly basis, EBITDA Margin rose 2115.0% year-over-year to 6.35% in Q2 2026; TTM through Jun 2026 was 7.63%, a 2780.0% increase from a year earlier, with the FY2025 full-year figure at 18.48%, up 1163.0% from the prior year.
- EBITDA Margin was 6.35% for Q2 2026 at Establishment Labs Holdings, up from 10.87% in the prior quarter.
- The five-year high for EBITDA Margin was 6.08% in Q4 2025, with the low at 70.07% in Q4 2023.
- Average EBITDA Margin over 5 years is 27.03%, with a median of 26.38% recorded in 2022.
- The sharpest annual moves came in 2023 and 2025: EBITDA Margin sank 4004 bps in 2023, then jumped 3586 bps in 2025.
- Over 5 years, EBITDA Margin stood at 30.04% in 2022, then slumped by 133 bps to 70.07% in 2023, then jumped by 40 bps to 41.94% in 2024, then jumped by 85 bps to 6.08% in 2025, then fell by 4 bps to 6.35% in 2026.
- The last three EBITDA Margin figures came in at 6.35% (Q2 2026), 10.87% (Q1 2026), and 6.08% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.14 Bn | 177.54 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 125.03 Bn | 119.81 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 117.95 Bn | 109.13 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 105.45 Bn | 101.97 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 66.16 Bn | 65.62 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 49.54 Bn | 45.29 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 33.69 Bn | 32.23 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 32.03 Bn | 30.08 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 21.01 Bn | 20.53 Bn | 684.20 Mn | 19.15% |
| 10 | Establishment Labs Holdings | 2.25 Bn | 2.18 Bn | 47.71 Mn | -6.35% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.35% |
| Mar 31, 2026 | -10.87% |
| Dec 31, 2025 | -6.08% |
| Sep 30, 2025 | -7.48% |
| Jun 30, 2025 | -27.50% |
| Mar 31, 2025 | -40.96% |
| Dec 31, 2024 | -41.94% |
| Sep 30, 2024 | -32.66% |
| Jun 30, 2024 | -21.18% |
| Mar 31, 2024 | -23.77% |
| Dec 31, 2023 | -70.07% |
| Sep 30, 2023 | -54.64% |
| Jun 30, 2023 | -28.24% |
| Mar 31, 2023 | -17.54% |
| Dec 31, 2022 | -30.04% |
| Sep 30, 2022 | -27.50% |
| Jun 30, 2022 | -25.26% |
| Mar 31, 2022 | -14.50% |
| Dec 31, 2021 | -26.52% |
| Sep 30, 2021 | -31.14% |